VEGFR-TKIs combined with chemotherapy for advanced non-small cell lung cancer: A systematic review

Introduction: To estimate the efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) in combination with chemotherapy for patients with advanced non-small cell lung cancer (NSCLC). Methods: We searched PubMed, PMC database, EMBASE, EBSCO-Medline, C...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Cancer
Main Authors: Liu, Lian, Zhang, Yue, Wei, Jia, Chen, Zhaoxin, Yu, Jing
Formato: Artigo
Idioma:Inglês
Publicado: Ivyspring International Publisher 2019
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6400799/
https://ncbi.nlm.nih.gov/pubmed/30854085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.29643
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares